These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2776833)

  • 1. Effects of MCI-154 on Ca2+ activation of skinned human myocardium.
    Perreault CL; Brozovich FV; Ransil BJ; Morgan JP
    Eur J Pharmacol; 1989 Jun; 165(2-3):305-8. PubMed ID: 2776833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats.
    Ming MJ; Hu D; Chen HS; Liu LM; Nan X; Hua CH; Lu RQ
    Shock; 2000 Dec; 14(6):652-6. PubMed ID: 11131917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
    Fujino K; Sperelakis N; Solaro RJ
    Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle.
    Kitada Y; Morita M; Narimatsu A
    Jpn J Pharmacol; 1989 Aug; 50(4):411-9. PubMed ID: 2789299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.
    Kitada Y; Narimatsu A; Matsumura N; Endo M
    J Pharmacol Exp Ther; 1987 Nov; 243(2):633-8. PubMed ID: 3500301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCI-154, a cardiac Ca2+ sensitizer, reverses the depression in maximal Ca2+-activated force by inorganic phosphate and acidic pH in skinned fiber of guinea pig heart.
    Kitada Y
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):611-8. PubMed ID: 9493698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MCI-154 on calcium sensitivity of contractile system and calcium release from sarcoplasmic reticulum in saponin-skinned rat myocardium.
    Huang Y; He ZH; Li YX
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):234-7. PubMed ID: 10072940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of the myofilaments to Ca2+ in human heart failure: implications for Ca2+ and force regulation.
    Hajjar RJ; Grossman W; Gwathmey JK
    Basic Res Cardiol; 1992; 87 Suppl 1():143-59. PubMed ID: 1497567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic and lusitropic effects of MCI-154 (6-[4-(4- pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone) on human myocardium.
    Warren SE; Kihara Y; Pesaturo J; Gwathmey JK; Phillips P; Morgan JP
    J Mol Cell Cardiol; 1989 Oct; 21(10):1037-45. PubMed ID: 2555525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel inotropic agent CGP 48506 alters force primarily by Ca(2+)-independent mechanisms in porcine skinned trabeculae.
    Palmer S; Di Bello S; Davenport SL; Herzig JW
    Cardiovasc Res; 1996 Aug; 32(2):411-21. PubMed ID: 8796129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
    Kitada Y; Abe Y; Narimatsu A; Tobe A
    J Pharmacol Exp Ther; 1991 May; 257(2):812-9. PubMed ID: 2033522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of DPI 201-106 on the sensitivity of the myofilaments to Ca2+ in intact and skinned trabeculae from control and myopathic human hearts.
    Hajjar RJ; Gwathmey JK; Briggs GM; Morgan JP
    J Clin Invest; 1988 Nov; 82(5):1578-84. PubMed ID: 3183055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial contractile system in endotoxemic rats.
    Mei JM; Hu DY; Chen HS; Liu LM; Xiao N; Chen HH; Lu RQ
    Acta Pharmacol Sin; 2000 Sep; 21(9):830-4. PubMed ID: 11501166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?
    Kitada Y; Narimatsu A; Matsumura N; Endo M
    Eur J Pharmacol; 1987 Feb; 134(2):229-31. PubMed ID: 3569412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
    Kitada Y; Kobayashi M; Narimatsu A; Ohizumi Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):272-7. PubMed ID: 2545860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'calcium sensitising' effects of ORG30029 in saponin- or Triton-skinned rat cardiac muscle.
    Miller DJ; Steele DS
    Br J Pharmacol; 1990 Aug; 100(4):843-9. PubMed ID: 2207503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers.
    Scheld HH; Fritsche R; Schlepper M; van Meel JC
    J Clin Pharmacol; 1989 Apr; 29(4):360-6. PubMed ID: 2723124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between steady-state force and intracellular [Ca2+] in intact human myocardium. Index of myofibrillar responsiveness to Ca2+.
    Gwathmey JK; Hajjar RJ
    Circulation; 1990 Oct; 82(4):1266-78. PubMed ID: 2205417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.
    Solaro RJ; Fujino K; Sperelakis N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S7-12. PubMed ID: 2478795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
    Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
    J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.